CalSTRS sees gains from NEA, but a decline from ARCH
Money manager sees strong gains with IVP, Aisling, JP Morgan funds
SFERS sees broad gains in recent vintage funds; adds Battery, OrbiMed
Performance at IVP XII, Clarus Lifesciences II improves last year
Record distributions in 2013; the role of consultants; pension asset growth slows
DN Capital founder Nenad Marovac says that Europe is bullish, thanks to good IPOs and expectations for Rocket Internet and Zalando
Union Square, OrbiMed lead venture portfolio; gains with funds of funds, too
Oregon PERS has more than 40 percent of its mid decade portfolio in funds of funds
Gains come slowly to venture portfolio despite diversified approach
Venture capital firms have staged a significant comeback since the woebegone years following the Internet bubble, and they could pose competition for LP dollars in the months ahead, according to analysis by VCJ affiliate publication Buyouts.